AAAAAA

   
Results: 1-12 |
Results: 12
Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: A southern Italy cooperative oncology group phase I/II study
Authors: Frasci, G D'Aiuto, G Comella, P Thomas, R Capasso, I Botti, G Cortino, GR De Rosa, V Comella, G
Citation: G. Frasci et al., Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: A southern Italy cooperative oncology group phase I/II study, SEMIN ONCOL, 28(3), 2001, pp. 50-56
A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study
Authors: Frasci, G Nicolella, G Comella, P Carreca, I DeCataldis, G Muci, D Brunetti, C Natale, M Piantedosi, F Russo, A Palmeri, S Comella, G Panza, N
Citation: G. Frasci et al., A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study, BR J CANC, 84(9), 2001, pp. 1166-1171
Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study
Authors: Frasci, G Comella, P D'Aiuto, G Thomas, R Capasso, I Elmo, M Botti, G Cortino, GR Lapenta, L De Rosa, V Vallone, P Petrillo, A Comella, G
Citation: G. Frasci et al., Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study, ANN ONCOL, 11(3), 2000, pp. 367-371
Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: Interim analysis of a phase III trial of the southern Italy Cooperative Oncology Group
Authors: Comella, P Frasci, G Panza, N Manzione, L De Cataldis, G Cioffi, R Maiorino, L Micillo, E Lorusso, V Di Rienzo, G Filippelli, G Lamberti, A Natale, M Bilancia, D Nicolella, G Di Nota, A Comella, G
Citation: P. Comella et al., Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: Interim analysis of a phase III trial of the southern Italy Cooperative Oncology Group, J CL ONCOL, 18(7), 2000, pp. 1451-1457
Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer
Authors: Lorusso, V Carpagnano, F Frasci, G Panza, N Di Rienzo, G Cisternino, ML Napoli, G Orlando, S Cinieri, S Brunetti, C Palazzo, S De Lena, M
Citation: V. Lorusso et al., Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer, J CL ONCOL, 18(2), 2000, pp. 405-411
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer
Authors: Frasci, G Lorusso, V Panza, N Comella, P Nicolella, G Bianco, A De Cataldis, G Iannelli, A Bilancia, D Belli, M Massidda, B Piantedosi, F Comella, G De Lena, M
Citation: G. Frasci et al., Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer, J CL ONCOL, 18(13), 2000, pp. 2529-2536
Ambamustine in the second-line treatment of patients with small-cell lung cancer - A phase II Fonicap study
Authors: Ardizzoni, A Antonelli, G Ricci, S Frasci, G Rinaldi, M Boni, L Galletti, P Pennucci, MC Antonuzzo, A Gravina, A Galli, L Comella, G Conte, PF Salvati, F Rosso, R
Citation: A. Ardizzoni et al., Ambamustine in the second-line treatment of patients with small-cell lung cancer - A phase II Fonicap study, AM J CL ONC, 23(1), 2000, pp. 22-25
Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study
Authors: Frasci, G D'Aiuto, G Comella, P Thomas, R Capasso, I Di Bonito, M Rivellini, F Carteni, G De Lucia, L Maiorino, L D'Aniello, R Frezza, P Lapenta, L Comella, G
Citation: G. Frasci et al., Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study, BREAST CANC, 62(2), 2000, pp. 87-97
Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study
Authors: Frasci, G Panza, N Comella, P Carteni, G Guida, T Nicolella, GP Natale, M Lombardi, R Apicella, A Pacilio, C Gravina, A Lapenta, L Comella, G
Citation: G. Frasci et al., Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study, ANN ONCOL, 10(3), 1999, pp. 355-358
Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: A phase I-II study
Authors: Frasci, G Panza, N Cornella, P Nicolella, GP Natale, M Manzione, L Bilancia, D Cioffi, R Maiorino, L De Cataldis, G Belli, M Micillo, E Mascia, V Massidda, B Lorusso, V De Lena, M Carpagnano, F Contu, A Pusceddu, G Comella, G
Citation: G. Frasci et al., Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: A phase I-II study, J CL ONCOL, 17(8), 1999, pp. 2316-2325
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: A phase II randomized study of the Southern ItalyCooperative Oncology Group
Authors: Comella, P Frasci, G Panza, N Manzione, L Lorusso, V Di Rienzo, G Cioffi, R De Cataldis, G Maiorino, L Bilancia, D Nicolella, G Natale, M Carpagnano, F Pacilio, C De Lena, M Bianco, A Comella, G
Citation: P. Comella et al., Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: A phase II randomized study of the Southern ItalyCooperative Oncology Group, J CL ONCOL, 17(5), 1999, pp. 1526-1534
Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group
Authors: Frasci, G D'Aiuto, G Comella, P Apicella, A Thomas, R Capasso, I Di Bonito, M Carteni, G Biglietto, M Lucia, LD Maiorino, L Piccolo, S Bianchi, U D'Aniello, R Lapenta, L Comella, G
Citation: G. Frasci et al., Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group, BREAST CANC, 56(3), 1999, pp. 239-252
Risultati: 1-12 |